For millions of people around the world, food allergies are a daily worry. A small amount of peanuts, milk, eggs, or seafood can trigger a severe reaction.
In some cases, the body responds so strongly that it leads to anaphylaxis, a life-threatening emergency that can cause breathing problems, a sudden drop in blood pressure, and even death if not treated quickly.
People at risk often carry emergency medication such as epinephrine injectors, but these are used only after symptoms begin. Now, scientists are developing a new wearable device that may help detect warning signs before a serious reaction happens.
Researchers at King Abdullah University of Science and Technology, also known as KAUST, have created a small skin patch called AllergE. This patch is designed to detect early immune changes linked to allergic reactions. The study describing this new technology was published in the journal ACS Materials Letters.
Food allergies are becoming more common worldwide. Traditional allergy testing methods usually involve skin prick tests or blood samples. These tests can be uncomfortable, time-consuming, and sometimes stressful, especially for children.
In rare cases, skin tests may even trigger mild allergic reactions. Because of these limits, doctors and families have long wanted a faster, safer, and less invasive way to monitor allergy risks.
The AllergE patch works in a different way. It uses tiny microneedles that are less than one millimeter long and about as thin as a human hair. These needles gently touch the fluid just beneath the surface of the skin. They are designed to be painless and do not go deep enough to cause bleeding. This makes the patch more comfortable and easier to use compared to traditional needles.
Inside each microneedle are special strands of DNA called aptamers. These strands are carefully designed to recognize immunoglobulin E, or IgE. IgE is an antibody produced by the immune system.
It plays a key role in allergic reactions. When a person with a food allergy is exposed to an allergen, IgE binds to that substance and triggers the release of chemicals that cause symptoms such as swelling, itching, and breathing problems.
When the aptamers in the patch come into contact with IgE, they change shape. This change creates a small electrical signal.
A flexible electrode in the patch measures this signal and sends the information to a small reader device. In the future, researchers hope the system could connect to a smartphone, allowing people to monitor their allergy-related immune levels at home in real time.
In laboratory testing, the patch showed strong performance. It was able to detect IgE at very low levels, as little as 30 picograms per milliliter. This is far more sensitive than many current testing methods.
The device also showed good specificity, meaning it could tell IgE apart from other similar antibodies that are common in the body but not responsible for allergic reactions. This ability is important because it reduces the risk of false alarms.
The microneedles are produced using an advanced 3D printing method known as two-photon polymerization. This technique allows researchers to carefully control the size, shape, and strength of each needle.
The needles are strong enough to stay intact during use, yet small enough to remain painless. They reach just deep enough to collect tiny amounts of skin fluid needed for testing without causing discomfort.
The idea for the AllergE patch was not only scientific but also personal. One of the researchers, Esraa Fakeih, was inspired by her own experience with severe food allergies in her family.
She and her young nieces suffered serious reactions after eating foods that contained small amounts of allergens. These frightening events motivated her to help create a device that could give early warning and possibly prevent dangerous episodes.
Although the AllergE patch is still in the early stages of development, the research team believes it could be part of a new generation of wearable health devices.
In the future, similar patches might track other immune markers, hormones, or signs of inflammation. This could help doctors and patients manage chronic conditions in a more preventive and personalized way.
When reviewing these findings, several points are important. First, the device has so far been tested mainly in laboratory settings and on donated skin samples, not yet in large human trials. More studies are needed to confirm how well it works in real-life situations.
Second, while detecting IgE early is promising, researchers must show that changes in IgE levels can reliably predict an upcoming allergic reaction. Third, cost, long-term comfort, and ease of daily use will also influence whether the device becomes widely adopted.
Despite these challenges, the study represents an exciting step forward. A painless, wearable sensor that warns people before a severe allergic reaction could shift allergy care from emergency response to prevention. For families living with constant fear of accidental exposure, even a few extra minutes of warning could make a life-saving difference.
If you care about cancer, please read studies that artificial sweeteners are linked to higher cancer risk, and how drinking milk affects risks of heart disease and cancer.
For more health information, please see recent studies about the best time to take vitamins to prevent heart disease, and results showing vitamin D supplements strongly reduces cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
